EV/EBITDA
-3.43
-0.11-3.31%
Wed, 27 Nov 2024 22:23:01 GMT
Summary:
Compass Therapeutics EV/EBITDA is currently -3.43, with a fall of -0.11 (-3.31%) during the most recent trading day. Over the past year, it has increased by +0.72 (+17.35%). CMPX EV/EBITDA is now -5000.00% below its all-time high of 0.07.CMPX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -3.3% |
| 1 m1 month | +11.1% |
| 3 m3 months | -17.9% |
| 6 m6 months | +5.3% |
| ytdytd | +13.4% |
| 1 y1 year | +17.4% |
| 5 y5 years | - |
CMPX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -2.91 | -17.9% | -4.29 | +20.1% |
| 3 m | 3 months | -2.63 | -30.4% | -4.71 | +27.2% |
| 6 m | 6 months | -1.65 | -107.9% | -4.71 | +27.2% |
| 1 y | 1 year | -1.65 | -107.9% | -5.81 | +41.0% |
| 3 y | 3 years | 0.07 | -5000.0% | -17.68 | +80.6% |
| 5 y | 5 years | 0.07 | -5000.0% | -17.68 | +80.6% |
| alltime | all time | 0.07 | -5000.0% | -17.68 | +80.6% |
Compass Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -3.43(-13.4%) |
| 2023 | -3.96(-75.5%) |
| Date | Value |
|---|---|
| 2022 | -16.16(+624.7%) |
| 2021 | -2.23 |
FAQ
- What is Compass Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Compass Therapeutics?
- What is CMPX EV/EBITDA year-to-date change?
- What is Compass Therapeutics EV/EBITDA year-on-year change?
What is Compass Therapeutics EV/EBITDA?
The current EV/EBITDA of CMPX is -3.43
What is the all time high EV/EBITDA for Compass Therapeutics?
Compass Therapeutics all-time high EV/EBITDA is 0.07
What is CMPX EV/EBITDA year-to-date change?
Compass Therapeutics EV/EBITDA has changed by +0.53 (+13.38%) since the beginning of the year
What is Compass Therapeutics EV/EBITDA year-on-year change?
Over the past year, CMPX EV/EBITDA has changed by +0.72 (+17.35%)